Search clinical trials for: PegIFN lambda

Total 474 results

Bristol-Myers Squibb

Completed

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen (LIRA-B)

Hepatitis B Virus

Australia, France, Germany, Korea, Republic of, Taiwan, United States, Canada, Italy, Netherlands, Singapore, Hong Kong
Eiger BioPharmaceuticals

Active, not recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV (LIMT-2)

Hepatitis Delta Virus

United States, France, Belgium, Spain, Italy, Turkey, Bulgaria, Germany, Israel, Romania, Georgia, Moldova, Republic of
Icahn School of Medicine at Mount Sinai
Eiger BioPharmaceuticals

Withdrawn

Interferon Lambda Therapy for COVID-19

SARS-CoV-2
Bristol-Myers Squibb

Completed

Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial

Hepatitis C

Argentina, Australia, Belgium, France, Germany, Italy, United States, Canada, Spain, Mexico, Austria, Poland, Netherlands, Korea, Republic of, Puerto Rico, New Zealand, Finland, Greece, Romania
Eiger BioPharmaceuticals

Completed

A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection (LIMT)

Hepatitis D, Chronic

Israel, New Zealand, Pakistan
Bristol-Myers Squibb

Completed

Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction (PK)

Chronic Hepatitis C Virus Infection | Chronic Hepatitis B Virus Infection

United States
Soroka University Medical Center

Completed

Pegylated Interferon Lambda for Treatment of COVID-19 Infection

COVID-19

Israel
Istanbul Medeniyet University

Active, not recruiting

Acupuncture for Persistent Dyspnea Despite Medical Treatment in COPD (COPD)

Acupuncture | COPD (Chronic Obstructive Pulmonary Disease)

Turkey
Stanford University

Completed

Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19 (COVID-Lambda)

COVID-19

United States
Bristol-Myers Squibb

Completed

Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia (MAGNITUDE)

Hepatitis C Virus

Australia, France, United States, Spain, Italy, Netherlands, Romania, Russian Federation
Tanta University

Completed

Comparative Trial of Custom-Made Titanium Plates Versus 3D Lambda Plates for Mandibular Subcondylar Fractures (SUBCONDPLATE)

Mandibular Sub-condylar Fracture

Egypt
Raymond Chung
Eiger BioPharmaceuticals

Terminated

Pegylated Interferon Lambda Treatment for COVID-19

COVID-19 | COVID

United States
Bristol-Myers Squibb

Completed

Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3 (PRINCIPAL)

Hepatitis C Virus (HCV)

Australia, Belgium, France, Italy, Japan, Korea, Republic of, Mexico, Russian Federation, Taiwan, United States, Chile, Hong Kong, Argentina, Netherlands, United Kingdom, Singapore, New Zealand, Finland, Greece
Henan Provincial People's Hospital
Xiamen Amoytop Biotech Co., Ltd.

Completed

Inactive HBsAg Carriers (IHCs) Treated With Pegylated Interferon α2b Based Intervention Therapy

Chronic Hepatitis B

China
ZymoGenetics

Completed

Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection

Hepatitis C, Chronic

United States, Canada
Nanogen Pharmaceutical Biotechnology Joint Stock...

Completed

The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients

Hepatitis C

Vietnam
University of British Columbia
University of Manitoba; University of North Carolina, Chapel Hill; University... and other collaborators

Not yet recruiting

Air Pollution and Inhaled Corticosteroids in COPD (APIC)

COPD
Biosplice Therapeutics, Inc.

Completed

Patient-Reported Outcomes in Evaluating Lorecivivint (SM04690) for Moderate to Severe Knee Osteoarthritis (STRIDES-1) (STRIDES-1)

Knee Osteoarthritis

United States
Queen's University
GlaxoSmithKline

Completed

Effect of a New Combination Bronchodilator on Exercise in GOLD Stage II Moderate COPD

COPD

Canada
LianBio LLC

Terminated

Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinoma

Gastric Cancer | Gastroesophageal Junction Adenocarcinoma

China
National Institute of Diabetes and Digestive and...

Withdrawn

Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis

Chronic Hepatitis Delta

United States
Johns Hopkins University
Eiger BioPharmaceuticals

Terminated

Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection (PROTECT)

Sars-CoV-2 Infection

United States
Puerta de Hierro University Hospital

Completed

Food Matrix and Genetic Variability as Determinants of Bioavailability and Biological Effects of Beta-cryptoxanthin and Phytosterols (foodmagenpol)

Hypercholesterolemia | Osteoporosis

Spain
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Unknown

Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB) (Bangabandhu)

Chronic Hepatitis B

Bangladesh
KU Leuven

Unknown

Systematic Approach for the Diagnosis and Treatment of Obstructive Lung Diseases (ACOS)

Chronic Obstructive Pulmonary Disease | Asthma | Overlap Syndrome

Belgium
Duke University
RTI International; Muhimbili University of Health and Allied Sciences

Completed

Efficacy Testing of a Culturally Relevant Stigma Intervention With WLWH in Tanzania

HIV | Depressive Symptoms | Self Efficacy | Stigma, Social | Self Esteem | Hope

Tanzania
Huashan Hospital

Not yet recruiting

Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative CHB Patients with Low Level HBsAg

Chronic Hepatitis B

China
Kansas City Heart Rhythm Research Foundation

Not yet recruiting

Assessing the Safety and Efficacy of the LAmbre™ Plus Device (REDUCE-AF)

Atrial Fibrillation
Boehringer Ingelheim

Completed

A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients

Hepatitis C

United States, Austria, Belgium, Canada, France, Germany, Japan, Korea, Republic of, Portugal, Romania, Russian Federation, Spain, Switzerland, Taiwan, United Kingdom
Boehringer Ingelheim

Withdrawn

A Phase III Study of BI201335 in Treatment-naive and Prior Relapser Patients With Chronic Hepatitis C Infection

Hepatitis C, Chronic
Lifetech Scientific (Shenzhen) Co., Ltd.
IQVIA Biotech

Completed

Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical Follow-up Study (LISA)

Atrial Fibrillation

China, Denmark, Germany, Ireland, Italy, Poland, Spain, Sweden, Thailand
Cairo University

Completed

Evaluation of CAMBRA Versus ICCMS Caries Risk Assessment Models Acquisition On Treatment Plan

Dental Caries

Egypt
GlaxoSmithKline

Completed

Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB) (B-Together)

Hepatitis B

Russian Federation, Spain, Canada, China, United States, Italy, Japan, Korea, Republic of, Poland, South Africa, United Kingdom
Boehringer Ingelheim

Completed

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 2)

Hepatitis C

United States, Canada, Korea, Republic of, Puerto Rico, Taiwan
Boehringer Ingelheim

Completed

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 1)

Hepatitis C

Austria, Belgium, France, Germany, Japan, Portugal, Romania, Russian Federation, Spain, Switzerland, United Kingdom
Centre Hospitalier René Dubos

Completed

Efficacy Assessment of Lamina Curved Plate in Managing Oroantral Communication (OACs) (CBSL)

Oroantral Fistula

France
Smith & Nephew, Inc.

Active, not recruiting

LEGION Hinge Safety and Efficacy Study (LINKS)

Knee Arthroplasty, Total

United States, Australia, Canada, Belgium, Spain
French Cardiology Society
Lifetech Scientific (Shenzhen) Co., Ltd.

Recruiting

Post-marketing Clinical Study of the LAMBRE System for Left Auricle Closure (ESCALLE)

Atrial Fibrillation

France
Boehringer Ingelheim

Completed

Effectiveness of Triple Therapy in COPD

Pulmonary Disease, Chronic Obstructive

United Kingdom
University Health Network, Toronto
Michael Garron Hospital

Completed

Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19 (ILIAD)

Covid-19 | Sars-CoV2

Canada, Brazil
University Health Network, Toronto

Active, not recruiting

TOGETHER - Toronto: Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19

Covid19 | Sars-CoV2

Canada
ARDEC Academy

Completed

Cortical Lamina for Alveolar Ridge Preservation (Lamina)

Tooth Extraction | Tooth Fracture | Periodontal Disease, AVDC Stage 4 | Hopeless Tooth | Periapical Infections

Cuba
Boehringer Ingelheim

Completed

Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)

Hepatitis C, Chronic

United States, Brazil, France, Germany, Italy, Spain, Switzerland, United Kingdom
Kamada, Ltd.

Completed

Phase II, Safety and Efficacy Study of Kamada-alpha-1-antitrypsin (AAT) for Inhalation"

Alpha-1 Antitrypsin Deficiency

United States
Icahn School of Medicine at Mount Sinai

Completed

Supporting Asthma Management Behaviors in Aging Adults (SAMBA)

Asthma

United States
Assiut University

Not yet recruiting

Short Acting Agents Vs Long Acting in Frequent Excerbator COPD Patients

Copd

Egypt
Shanghai 10th People's Hospital
Lifetech Scientific (Shenzhen) Co., Ltd.

Completed

Left Atrial Appendage Closure With the LAmbre

Stroke | Atrial Fibrillation | Left Atrial Appendage Closure
Orion Biotech Inc.
Taipei Veterans General Hospital, Taiwan

Completed

Clinical Evaluation of Orion Lamina Cover in Patients Undergoing Lumbar Laminectomy With Instrumented Fusion

Scoliosis | Spinal Stenosis | Degenerative Spondylolisthesis | Degenerative Lumbar Spinal Stenosis | Spinal Fracture

Taiwan
Foundation for Liver Research

Completed

Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB (PEGON)

Chronic Hepatitis B

Netherlands, China
Merck Sharp & Dohme LLC

Terminated

A Study of Pegylated Interferon Alfa-2b (MK-4031) as an Adjuvant Treatment in Japanese Patients With Malignant Melanoma (MK-4031-370)

Malignant Melanoma

Search clinical trials for: PegIFN lambda

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations